Ohio Administrative Code|Rule 3701:1-58-42 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries).

                                                
Except as provided in rule 3701:1-58-21 of the
		Administrative Code, the licensee shall require an authorized user for the oral
		administration of sodium iodide iodine-131 requiring a written directive in
		quantities greater than 1.22 gigabecquerels (thirty-three millicuries) to be a
		physician who:
(A) Is certified by a medical specialty
		  board whose certification process includes all of the requirements in
		  paragraphs (C)(1) and (C)(2) of this rule, and whose certification has been
		  recognized by the director, the United States nuclear regulatory commission, or
		  an agreement state. The names of board certifications which have been
		  recognized by the director, the United States nuclear regulatory commission, or
		  an agreement state will be posted on the United States nuclear regulatory
		  commission's "Medical Uses Licensee Toolkit" web page at
		  www.nrc.gov.; or
(B) Is an authorized user under rule
		  3701:1-58-40 of the Administrative Code, for uses listed in paragraph
		  (B)(1)(b)(vi)(b) of rule 3701:1-58-40 of the Administrative Code, or equivalent
		  United States nuclear regulatory commission or agreement state requirements;
		  or
(C) Has achieved the following
		  requirements:
(1) Has successfully
			 completed eighty hours of classroom and laboratory training, applicable to the
			 medical use of sodium iodide iodine-131 for procedures requiring a written
			 directive. The training must include:
(a) Radiation physics and instrumentation;
(b) Radiation protection;
(c) Mathematics pertaining to the use and measurement of
				radioactivity;
(d) Chemistry of radioactive material for medical use;
				and
(e) Radiation biology;
(2) Has work experience,
			 under the supervision of an authorized user who meets the requirements in rule
			 3701:1-58-21, 3701:1-58-40, or this rule of the Administrative Code, or
			 equivalent United States nuclear regulatory commission or agreement state
			 requirements. A supervising authorized user who meets the requirements in
			 paragraph (B) of rule 3701:1-58-40 of the Administrative Code, must have
			 experience in administering dosages as specified in paragraph (B)(1)(b)(vi)(b)
			 of rule 3701:1-58-40 of the Administrative Code. The work experience must
			 involve:
(a) Ordering, receiving, and unpacking radioactive materials
				safely and performing the related radiation surveys;
(b) Performing quality control procedures on instruments used to
				determine the activity of dosages and performing checks for proper operation of
				survey meters;
(c) Calculating, measuring, and safely preparing patient or human
				research subject dosages;
(d) Using administrative controls to prevent a medical event
				involving the use of radioactive material;
(e) Using procedures to contain spilled radioactive material
				safely and using proper decontamination procedures; and
(f) Administering dosages to patients or human research subjects,
				that includes at least three cases involving the oral administration of greater
				than 1.22 gigabecquerels (thirty-three millicuries) of sodium iodide
				iodine-131; and
(3) Has obtained written
			 attestation that the individual has satisfactorily completed the requirements
			 in paragraphs (C)(1) and (C)(2) of this rule, and is able to independently
			 fulfill the radiation safety-related duties as an authorized user for oral
			 administration of greater than 1.22 gigabecquerels (thirty-three millicuries)
			 of sodium iodide I-131 for medical uses authorized under rule 3701:1-58-37 of
			 the Administrative Code. The attestation must be obtained from
			 either:
(a) A preceptor authorized user who meets the requirements
				in rule 3701:1-58-21, 3701:1-58-40, or this rule of the Administrative Code, or
				equivalent United States nuclear regulatory commission or agreement state
				requirements, and has experience in administering dosages as specified in
				paragraph (B)(1)(b)(vii)(b) of rule 3701:1-58-40 of the Administrative Code;
				or
(b) A residency program director who affirms in writing
				that the attestation represents the consensus of the residency program faculty
				where at least one faculty member is an authorized user who meets the
				requirements in rule 3701:1-58-21, 3701:1-58-40, or this rule of the
				Administrative Code, or equivalent United States nuclear regulatory commission
				or agreement state requirements, has experience in administering dosages as
				specified in paragraph (B)(1)(b)(vii)(b) of rule 3701:1-58-40 of the
				Administrative Code, and concurs with the attestation provided by the residency
				program director. The residency training program must be approved by the
				residency review committee of the "Accreditation Council for Graduate
				Medical Education," the "Royal College of Physicians and Surgeons of
				Canada," or the "Council on Postdoctoral Training of the American
				Osteopathic Association," and must include training and experience
				specified in paragraphs (C)(1) and (C)(2) of this rule.


Last updated August 15, 2021 at 12:10 AM